SABS EPS Estimates - SAB Biotherapeutics, Inc. logo

SABS EPS Estimates

SAB Biotherapeutics, Inc.

$3.20
+$0.25(+8.47%)
30
Overall
60
Value
10
Tech
21
Quality
How is this score calculated?
Market Cap
$288.28M
Volume
886.27K
52W Range
$2.44 - $5.15
Target Price
$12.00

SABS EPS estimates: the consensus estimate for SAB Biotherapeutics, Inc.'s current fiscal year is -$1.13 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.

SABS EPS Estimates

EPS estimate, current quarter
$-0.26
EPS estimate, current year
$-1.13
EPS estimate, next year
$-0.87
EPS growth, 3-year
+27.06%
SABS reported EPS by year
Fiscal yearEPS
2025$0.22
2024$-3.68
2023$-7.64
2022$-4.30
2021$-6.30
ABCD
1SymbolPriceChangeVol
2SABS$3.20+8.5%886.27K
3
4
5
6

Get SAB Biotherapeutics, Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.